Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.
CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.
While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
| Specialty Retail Industry | Consumer Discretionary Sector | Denise Dignam CEO | XFRA Exchange | US1638511089 ISIN |
| US Country | 6,000 Employees | 27 Feb 2026 Last Dividend | - Last Split | - IPO Date |
The Chemours Company is a leading provider of performance chemicals with a global footprint, extending services across North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. Founded in 2014 and headquartered in Wilmington, Delaware, Chemours operates through three key segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The company caters to a diverse range of industries, from construction and packaging to electronics and energy, leveraging direct and indirect sales channels as well as a network of resellers and distributors to reach its customers.
The Chemours Company's diverse product portfolio is broken down into three main segments, each offering specialized chemical solutions: